Ethiodol

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
BACKGROUND Unresectable colorectal liver metastases have a 1- and 2-year survival of 55% and 33% with current systemic therapies… (More)
Is this relevant?
2011
2011
BACKGROUND Unresectable intrahepatic cholangiocarcinoma has a poor prognosis, with a median survival of 5 to 8 months without… (More)
Is this relevant?
2010
2010
OBJECTIVE Linear measurements, such as those described by the Response Evaluation Criteria in Solid Tumors (RECIST) criteria, may… (More)
Is this relevant?
2002
2002
RATIONALE AND OBJECTIVES To evaluate the effect of capillary embolization with superselectively administered 1:1 Ethiodol-ethanol… (More)
Is this relevant?
2001
2001
PURPOSE To evaluate the response to and survival after chemoembolization with cisplatin, doxorubicin, mitomycin-C, Ethiodol, and… (More)
Is this relevant?
2000
2000
OBJECTIVE Cyanoacrylates are the most commonly used liquid embolic agents. For embolization of arteriovenous malformations, a… (More)
Is this relevant?
1999
1999
PURPOSE To evaluate response and survival after hepatic chemoembolization with cisplatin, doxorubicin, mitomycin-C, Ethiodol, and… (More)
Is this relevant?
1986
1986
This study assesses the therapeutic efficacy of radiolabeled iodized oil on a patient with hepatocellular carcinoma (HCC). An… (More)
Is this relevant?
Highly Cited
1985
Highly Cited
1985
Transcatheter arterial embolization (TAE) was performed in 97 patients with hepatocellular carcinoma. Ethiodol (iodized oil… (More)
Is this relevant?
Highly Cited
1983
Highly Cited
1983
A clinical evaluation of arterial infusion of high-molecular-weight antitumor agent SMANCS dissolved in lipid lymphographic agent… (More)
Is this relevant?